默克藥廠MRK
紐約證券 · USD
78.12
-3.63
(-4.44%)
收盤 08/01 04:00 (UTC+8)
盤後
78.05
78.05
(-0.09%)
08/01 04:00 (UTC+8)
默克藥廠MRK
78.12
-3.63
(-4.44%)
財務數據
損益表
- 138.30
- 144.87
- 150.35
- 159.63
- 146.30
- 157.75
- 161.12
- 166.57
- 156.24
- 155.29
- -7.55
- 4.75
- 3.78
- 6.17
- -8.35
- 7.83
- 2.14
- 3.38
- -6.20
- -0.61
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 15,529,000 | 15,624,000 | 16,657,000 | 16,112,000 | 15,775,000 | 14,630,000 | 15,963,000 | 15,035,000 | 14,487,000 | 13,830,000 |
營業成本 | 3,419,000 | 3,828,000 | 4,080,000 | 3,745,000 | 3,540,000 | 3,912,000 | 4,263,000 | 4,025,000 | 3,926,000 | 3,881,000 |
營業毛利 | 12,110,000 | 11,796,000 | 12,577,000 | 12,367,000 | 12,235,000 | 10,718,000 | 11,700,000 | 11,010,000 | 10,561,000 | 9,949,000 |
營業費用 | - | - | 8,649,000 | 6,317,000 | 6,598,000 | 12,686,000 | 5,951,000 | 16,175,000 | 6,822,000 | 6,511,000 |
研發費用 | 3,621,000 | 4,584,000 | 5,862,000 | 3,500,000 | 3,992,000 | 9,627,000 | 3,307,000 | 13,321,000 | 4,276,000 | 3,775,000 |
推銷及管理費用 | 2,552,000 | 2,864,000 | 2,731,000 | 2,738,000 | 2,483,000 | 2,804,000 | 2,518,000 | 2,703,000 | 2,479,000 | 2,687,000 |
非經常性項目費用 | 69,000 | 51,000 | 56,000 | 79,000 | 123,000 | 255,000 | 126,000 | 151,000 | 67,000 | 49,000 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 5,868,000 | 4,297,000 | 3,928,000 | 6,050,000 | 5,637,000 | -1,968,000 | 5,749,000 | -5,165,000 | 3,739,000 | 3,438,000 |
其他收入及費用 | 35,000 | -127,000 | 163,000 | -45,000 | 33,000 | -78,000 | -129,000 | -170,000 | -89,000 | 75,000 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 5,903,000 | 4,170,000 | 4,091,000 | 6,005,000 | 5,670,000 | -2,046,000 | 5,620,000 | -5,335,000 | 3,650,000 | 3,513,000 |
所得稅 | 818,000 | 426,000 | 930,000 | 544,000 | 903,000 | -820,000 | 870,000 | 637,000 | 825,000 | 495,000 |
稅後純益 | 5,079,000 | 3,743,000 | 3,157,000 | 5,455,000 | 4,762,000 | -1,226,000 | 4,745,000 | -5,975,000 | 2,821,000 | 3,017,000 |
基本每股稅後盈餘(元) | 2.02 | 1.48 | 1.25 | 2.15 | 1.88 | -0.48 | 1.87 | -2.35 | 1.11 | 1.19 |
稀釋每股稅後盈餘(元) | 2.01 | 1.48 | 1.24 | 2.15 | 1.87 | -0.48 | 1.86 | -2.35 | 1.11 | 1.18 |
基本平均股數(千股) | 2516394.00 | 2527637.00 | 2532030.00 | 2535649.00 | 2532700.00 | 2554166.00 | 2535293.00 | 2539000.00 | 2538000.00 | 2536000.00 |
稀釋平均股數(千股) | 2531000.00 | 2537000.00 | 2541000.00 | 2544000.00 | 2544000.00 | 2554166.00 | 2546000.00 | 2539000.00 | 2551000.00 | 2548000.00 |
還原基本每股稅後盈餘(元) | 2.02 | 1.48 | 1.25 | 2.15 | 1.88 | -0.48 | 1.87 | -2.35 | 1.11 | 1.19 |
還原稀釋每股稅後盈餘(元) | 2.01 | 1.48 | 1.24 | 2.15 | 1.87 | -0.48 | 1.86 | -2.35 | 1.11 | 1.18 |
還原基本平均股數(千股) | 2,516,394 | 2,527,637 | 2,532,030 | 2,535,649 | 2,532,700 | 2,554,166 | 2,535,293 | 2,539,000 | 2,538,000 | 2,536,000 |
還原稀釋平均股數(千股) | 2,531,000 | 2,537,000 | 2,541,000 | 2,544,000 | 2,544,000 | 2,554,166 | 2,546,000 | 2,539,000 | 2,551,000 | 2,548,000 |
EBITDA(千元) | 6,996,000 | 5,366,000 | 5,273,000 | 7,131,000 | 6,649,000 | -1,082,000 | 6,629,000 | -4,435,000 | 4,637,000 | 4,404,000 |